A new EU project, METSY, develops and applies neuroimaging and bioinformatics tools to study how lipid metabolism is connected to psychotic disorders and metabolic co-morbidities such as metabolic syndrome and diabetes.
The overall objective is to identify, prioritize and evaluate multi-modal blood and neuroimaging biomarkers that have diagnostic potential for prediction and monitoring psychotic disorders and associated metabolic co-morbidities. The consortium brings together clinicians, researchers and industry partners in the domains of psychiatry, neuroimaging, metabolic research, systems biology and bioinformatics.
The 4-year EU-project is coordinated by Research Professor Matej Oreič from VTT Technical Research Centre of Finland. Total budget for the project is 5.94 million , of which the EU's share is 4.23 million.
Project partners: VTT Technical Research Centre of Finland, Biomax Informatics AG (Germany), Servicio Madrileo de Salud (Spain), University of Turku (Finland), National Institute for Health and Welfare (Finland), Philips Research (Germany), King's College London (UK).
|Contact: Matej Orešič|
VTT Technical Research Centre of Finland